Next Article in Journal
Immunogenicity and Protective Efficacy of an mRNA Vaccine Targeting HSV-2 UL41 in Mice
Next Article in Special Issue
Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1
Previous Article in Journal
Navigating the Road to Immunization Equity: Systematic Review of Challenges in Introducing New Vaccines into Sub-Saharan Africa’s Health Systems
Previous Article in Special Issue
Evaluating Antigen- and Vector-Specific Immune Responses of a Recombinant Pichinde Virus-Based Vaccine Expressing the Lymphocytic Choriomeningitis Virus Nucleoprotein
 
 
Article

Article Versions Notes

Vaccines 2025, 13(3), 270; https://doi.org/10.3390/vaccines13030270
Action Date Notes Link
article pdf uploaded. 4 March 2025 16:14 CET Version of Record https://www.mdpi.com/2076-393X/13/3/270/pdf-vor
article xml file uploaded 5 March 2025 05:01 CET Original file -
article xml uploaded. 5 March 2025 05:01 CET Update https://www.mdpi.com/2076-393X/13/3/270/xml
article pdf uploaded. 5 March 2025 05:01 CET Updated version of record https://www.mdpi.com/2076-393X/13/3/270/pdf
article html file updated 5 March 2025 05:04 CET Original file https://www.mdpi.com/2076-393X/13/3/270/html
Back to TopTop